A prospective observational study to evaluate the effects of long-acting somatostatin analogs on 68Ga-DOTATATE uptake in patients with neuroendocrine tumors
A Gålne, H Almquist, M Almquist… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Patients with neuroendocrine tumors (NETs) are often treated with somatostatin analogs
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
(SSAs) for control of symptoms and tumor growth. Such therapy could theoretically lead to …
68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor–mediated radionuclide therapy in patients with well-differentiated …
AR Haug, CJ Auernhammer, B Wängler… - Journal of nuclear …, 2010 - Soc Nuclear Med
We aimed to evaluate 68Ga-DOTATATE PET/CT for the early prediction of time to
progression and clinical outcome after a first cycle of peptide receptor radionuclide treatment …
progression and clinical outcome after a first cycle of peptide receptor radionuclide treatment …